Advancing Low-Temperature Performance: Testing, Trends, and Containment for Cell Therapies

As cell and gene therapies continue to advance, maintaining product integrity through cold and cryogenic storage is placing greater demands on packaging and containment systems. Materials that perform predictably under standard conditions can behave differently at extremely low temperatures, making testing strategy, material selection, and container closure integrity increasingly important considerations. 

This webinar will examine the scientific, technical, and regulatory factors shaping low-temperature containment strategies for cell therapies, including how component properties can change under cold and cryogenic conditions and what those changes may mean for product performance. 

You’ll gain insights into: 

• How low temperatures can affect the mechanical and functional properties of packaging and delivery components 

• Key considerations when evaluating materials and containment systems for cryogenic applications 

• Industry and regulatory trends contributing to greater scrutiny of low-temperature performance 

• Approaches to assessing container closure integrity under extreme storage conditions 

• Findings from an allogeneic cell therapy case study examining cryopreservation, post-thaw recovery and function, and container performance at -180°C 

The discussion will connect testing principles with practical considerations that can help development, manufacturing, and quality teams make more informed decisions as cryogenic cell therapy programs progress. Register today to join us!